
Nanoparticle Drug Delivery
Richard Liang 18’ Mucoadhesive particles (MAPs) are used as the primary method of pulmonary drug delivery since it was believed that they increase drug duration within the lungs. MAPs act by sticking to the mucus layers and are used to treat a variety of illnesses including asthma, cystic fibrosis and lung cancer. However, administered MAPs are, in reality, quickly removed from the body via physiologic … Continue reading Nanoparticle Drug Delivery